A NEW ERA FOR CANCER THERAPY

OUR MISSION

At OncoTEX Inc., we’re on a mission to treat cancer effectively, without the prohibitive side effects we know today.

We are addressing an urgent major unmet clinical need by transforming cancer therapy with TEX Core, an oncology drug platform that can create a new suite of life-changing cancer therapeutics.

OncoTEX Inc. is a proud member of The iQ Group Global, a consortium of companies who work together to find, fund and develop bioscience discoveries to create life-changing medical innovations..

Tex Core

A world first platform, TEX Core conjugates with oncology therapies to create novel oncology compounds that are delivered directly to tumor cells, with minimal side effects.

TEX Core-developed compounds are designed to be tumor localizing, well-tolerated, MRI-detectable and efficacious in multiple solid tumors, including cancer cells that fail to respond to current therapies.

OXALITEX: THE FIRST TEX CORE COMPOUND

The first TEX Core oncology compound to be developed is OxaliTEX, which localizes to solid tumors including ovarian, lung and colorectal cancers.

OxaliTEX activates within cancer cells, overcoming multiple mechanisms of resistance and minimizing toxic side effects. The lead indication for OxaliTEX is ovarian cancer, the number one cause of gynecological cancer deaths globally.

A NEW FUTURE FOR PATIENTS WITH CANCER

Almost half of all chemotherapy patients are treated with platinum-based drugs such as cisplatin, carboplatin and oxaliplatin

86% of patients experience side effects from traditional chemotherapy treatments and 27% of those side effects are potentially life threatening

Drug treatment resistance is responsible for up to 90% of cancer related deaths

Request Further Information

Member of The iQ Group Global

OncoTEX Inc. is a proud member of The iQ Group Global, a consortium of companies who work together to find, fund and develop bioscience discoveries into life-changing medical innovations – and take them to the people who need them most.

The iQ Group Global